Repository logo
 
Publication

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women

dc.contributor.authorBártolo, Inês
dc.contributor.authorDiniz, Ana Rita
dc.contributor.authorBorrego, Pedro
dc.contributor.authorFerreira, João Pedro
dc.contributor.authorBronze, Maria Rosário
dc.contributor.authorBarroso, Helena
dc.contributor.authorPinto, Rui
dc.contributor.authorCardoso, Carlos
dc.contributor.authorPinto, João F.
dc.contributor.authorDiaz, Rafael Ceña
dc.contributor.authorBroncano, Pilar Garcia
dc.contributor.authorMuñoz-Fernández, Maria Angel
dc.contributor.authorTaveira, Nuno
dc.date.accessioned2019-11-18T15:58:01Z
dc.date.available2019-11-18T15:58:01Z
dc.date.issued2018-04
dc.descriptionThis is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.pt_PT
dc.description.abstractMicrobicides are an important strategy for preventing the sexual transmission of HIV but, so far, the most advanced tenofovir-based microbicides have had modest efficacy. This has been related to adherence problems and high prevalence of tenofovir-resistant HIV-1 strains. P3 is a new peptide with potent activity against HIV that may be a good microbicide candidate. In this work P3 was formulated in a gel of hydroxyethyl cellulose and its activity, stability and safety profile in Balb/c mice were evaluated. HIV infection was fully blocked by a 1.5% gel containing P3 at the IC90 (366.4 nM) concentration. The antiviral activity did not change at 4°C during 4 months and at 25, 37 and 65°C for 1 week. P3 was stable and fully functional at acidic pH up to 24h, under different concentrations of hydrogen peroxide and in the presence of genital fluids up to 48h. P3 had no antibacterial activity and did not affect sperm motility and vitality. Finally, P3 didn't cause significant alterations in the vaginal epithelium of Balb/c mice at 0.06 (456.8 μM) and 0.2 mg/day (1522.7 μM) doses. These findings indicate that P3 is an excellent candidate for further development as a microbicide gel for the prevention of HIV transmission in women.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBártolo I, Diniz AR, Borrego P, Ferreira JP, Bronze MR, Barroso H, et al. (2018) Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women. PLoS ONE 13(4): e0195744. https://doi.org/10.1371/journal.pone.0195744pt_PT
dc.identifier.doi10.1371/journal.pone.0195744pt_PT
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10400.26/30191
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherPLoSpt_PT
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0195744pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectMicrobicidespt_PT
dc.subjectHIV transmissionpt_PT
dc.subjectPreventionpt_PT
dc.subjectWomenpt_PT
dc.titleEvaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in womenpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPagee0197015pt_PT
oaire.citation.titlePLoS Onept_PT
oaire.citation.volume13(5)pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ArtigoHBarroso_2019_01.pdf
Size:
6.47 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: